$LGND 3 SEC Filings

Filed On	Filing
03 Jul 2025	Form 3: Ligand Pharmaceuticals Inc, 10% owner · Pelthos Therapeutics Inc
25 Sep 2023	Form 3: Zimmermann Martine, Director No securities owned
07 Nov 2022	Form 3: Espinoza Octavio, Chief Financial Officer Holds 10,553 shares of Common Stock
07 Nov 2022	Form 3: Reardon Andrew, See Remarks Holds 12,013 shares of Common Stock
30 Sep 2022	Form 3: Ligand Pharmaceuticals Inc, 10% owner · OmniAb Operations, Inc. Holds 1,000 shares of Common Stock
29 Jun 2022	Form 3: Haas Jason, Director No securities owned
14 Jul 2021	Form 3: Cochran Jennifer R., Director No securities owned
09 Oct 2020	Form 3: Ligand Pharmaceuticals Inc, 10% owner · Pfenex Inc. Holds 27,034,437 shares of Common Stock
14 Feb 2020	Form 3: Goldman Sachs Group Inc, 10% owner and 1 other Holds 686,330 shares of Common Units
15 Oct 2019	Form 3: Boyce Sarah, Director No securities owned
22 Aug 2017	Form 3: Gray Nancy Ryan, Director No securities owned
06 Aug 2015	Form 3: Korenberg Matthew E, VP, Finance and CFO No securities owned
07 May 2015	Form 3: Ligand Pharmaceuticals Inc, 10% owner · Viking Therapeutics, Inc. Holds 4,552,859 shares of Common Stock
11 Apr 2014	Form 3: Herman Melanie J, Director of Accounting Holds 2,630 shares of Common Stock
11 Jan 2013	Form 3: Investment 10 Llc, See Explanation of Responses Holds 272,475 shares of Common Stock, $0.001 par value
06 Jul 2011	Form 3: Bvf Partners L P/IL, 10% owner and 5 others Holds 462,836 shares of Common Stock, par value $0.001
20 Apr 2011	Form 3: Foehr Matthew W, EVP and COO No securities owned
10 Feb 2011	Form 3: Lamattina John L, Director No securities owned
08 Oct 2010	Form 3: Patel Sunil, Director Holds 10,000 shares of Common Stock
24 Dec 2008	Form 3: Peacock Bruce, Director Holds 10,000 shares of Common Stock

Comments